Offering Methadone Treatment To Drug Users Significantly Reduces HIV Infection, Transmission Risk, Study Shows

Offering methadone treatment to people who use injection drugs “substantially reduces the risk that they will get HIV or give it to anyone else,” according to a BMJ study published this month that pools data from studies done in nine countries, the New York Times reports. “Methadone itself does not affect the virus; scientists believe it works because [drug users] on treatment become better able to stop sharing needles and selling sex for drugs,” the newspaper writes, noting “the risk of catching HIV is one in 125 from a syringe, about one in 122 from anal sex, and less than one in 2,000 from vaginal sex, according to an editorial published with the study.” The newspaper adds, “Many countries, including Russia, have large HIV epidemics among addicts but nonetheless outlaw methadone and buprenorphine treatment for political, religious, or other reasons” (McNeil, 10/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.